CENE Event - The Cross-Border Story of Biotech Manufacturer iVexsol

Join CENE on Thursday May 20th at 2:00 PM (Eastern time) as we welcome Rodney Rietze, PhD, Co-founder and CEO of iVexSol.

The company has developed an advanced manufacturing process for lentiviral vectors, gene-editing reagents, that are critical components in the manufacturing processes of cell and gene therapies (CGTs).

Dr. Rietze began his studies at the University of Calgary. In 2019, Next Generation Manufacturing Canada (NGen) funded iVexSol Canada to develop a manufacturing facility in Canada.

Find out more about Dr. Rietze's journey from the University of Calgary to iVexSol and manufacturing in Canada in this CENE program moderated by CENE Board Member Vinit Nijhawan, Managing Director, MassVentures.

Attendance at this program on Zoom is free and open to the public but pre-registration is required.

Register Here